Abstract
Purpose. The aim of this study was to characterize the intracellular fate and nuclear uptake kinetics of oligonucleotides (ON) that were complexed with protamine sulfate (PS) and negatively charged liposomes at different ratios of ON to PS.
Methods. Double-fluorescence labelling of ON and liposomal lipid was applied to simultaneously monitor the interaction as well as the individual fate of active agent and carrier upon intracellular delivery using confocal laser scanning microscopy (CLSM). A DNA-analogue of a 68-mer intramolecular double-stranded RNA:DNA-hybridoligo- nucleotide (chimeraplasts) with unmodified phosphate backbone was employed. This construct was condensed with PS and coated with a liposomal formulation (AVE™-3 = artificial viral envelope).
Results. PS-ON complexes and AVE™-3-coated complexes with a defined composition were very effective in nuclear transport of ON for a ON:PS charge ratio of 1:3. Nucleus:cytosol fluorescence ratios peaked at about 10 hrs and started to decrease again at 21 hrs.
Conclusions. AVE™ associates with PS-condensed ON, and this complex is able to be taken up by cells and to deliver ON to the nucleus. PS-ON complexes are released from the liposomal formulation, mainly as an extranuclear enzymatic degradation of the liposomal phospholipids. The results of the kinetic analysis can be used to optimize transfection protocols with ON in HepG2 cells.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
O. Zelphati and F. C. Szoka, Jr. Liposomes as a carrier for intracellular delivery of antisense oligonucleotides: a real or magic bullet? J Contr Rel 41:99–119 (1996).
K. Yoon, A. Cole Strauss, and E. B. Kmiec. Targeted gene correction of episomal DNA in mammalian cells mediated by a chimeric RNA.DNA oligonucleotide. Proc Natl Acad Sci USA 93: 2071–2076 (1996).
A. Cole Strauss, K. Yoon, Y. Xiang, B. C. Byrne, M. C. Rice, J. Gryn, W. K. Holloman, and E. B. Kmiec. Correction of the mutation responsible for sickle cell anemia by an RNA-DNA oligonucleotide [see comments]. Science 273:1386–1389 (1996).
F. D. Ledley. Pharmaceutical approach to somatic gene therapy. Pharm. Res. 13:1595–1613 (1996).
O. Zelphati and F. C. Szoka Jr. Intracellular distribution and mechanism of delivery of oligonucleotides mediated by cationic lipids. Pharm. Res. 13:1367–1372 (1996).
R. M. Bennett. As nature intended? The uptake of DNA and oligonucleotides by eukaryotic cells. Antisense Res Dev 3:235–241 (1993).
R. Chander and H. Schreier. Artificial viral envelopes containing recombinant human immunodeficiency virus (HIV) gp160. Life Sci 50:481–489 (1992).
R. C. Aloia, F. C. Jensen, C. C. Curtain, P. W. Mobley, and L. M. Gordon. Lipid composition and fluidity of the human immunodeficiency virus. Proc Natl Acad Sci USA 85:900–904 (1988).
H. Schreier, M. Ausborn, S. Günther, V. Weissig, and R. Chander. (Patho)physiologic pathways to drug targeting: artificial viral envelopes. J Mol Recognit 8:59–62 (1995).
S. L. Loke, C. Stein, X. Zhang, M. Avigan, J. Cohen, and L. M. Neckers. Delivery of c-myc antisense phosphorothioate oligodeoxynucleotides to hematopoietic cells in culture by liposome fusion: specific reduction in c-myc protein expression correlates with inhibition of cell growth and DNA synthesis. Curr Top Microbiol Immunol 141:282–289 (1988).
A. R. Thierry, A. Rahman, and A. Dritschilo. Overcoming multidrug resistance in human tumor cells using free and liposomally encapsulated antisense oligodeoxynucleotides. Biochem Biophys Res Commun 190:952–960 (1993).
R. M. Santella, and H. J. Li. Studies on interaction between poly(L-lysine58,L-phenylalanine42) and deoxyribonucleic acids. Biochemistry 14:3604–3611 (1975).
I. Baeza, P. Gariglio, L. M. Rangel, P. Chavez, L. Cervantes, C. Arguello, C. Wong, and C. Montanez. Electron microscopy and biochemical properties of polyamine-compacted DNA. Biochemistry 26:6387–6392 (1987).
T. Ando, M. Yamasaki, and K. Suzuki. Protamines. Isolation, characterization, structure and function. Mol Biol Biochem Biophys 12:1–114 (1973).
H. K. Amos and K. E. Earnes. Influence of bacterial ribonucleic acid on animal cell culture. II. Protamine enhancement of RNA uptake. Exp Cell Res 32:14–25 (1963).
T. Wilczok and J. Mendicki. The effect of protamines and histones on incorporation of donor DNA into neoplastic cells. Neoplasma (Bratisl.) 10:113–119 (1963).
J. Mendicki and T. Wilczok. The interaction of basic proteins during the donor DNA incorporation into neoplastic cells. Neoplasma (Bratisl.) 10:561–564 (1963).
F. L. Sorgi, S. Bhattacharya, and L. Huang. Protamine sulfate enhances lipid-mediated gene transfer. Gene Therapy 4:961–968 (1997).
K. Valnes and P. Brandtzaeg. Retardation of immunofluorescence fading during microscopy. J Histochem Cytochem 33:755–761 (1985).
A. R. Thierry and A. Dritschilo. Intracellular availability of unmodified, phosphorothioated and liposomally encapsulated oligodeoxynucleotides for antisense activity. Nucleic Acids Res 20: 5691–5698 (1992).
L. A. Yakubov, E. A. Deeva, V. F. Zarytova, E. M. Ivanova, A. S. Ryte, L. V. Yurchenko, and V. V. Vlassov. Mechanism of oligonucleotide uptake by cells: involvement of specific receptors? Proc Natl Acad Sci USA 86:6454–6458 (1989).
S. Wu Pong, T. L. Weiss, and C. A. Hunt. Antisense c-myc oligodeoxyribonucleotide cellular uptake. Pharm Res 9:1010–1017 (1992).
C. A. Stein, J. L. Tonkinson, L. M. Zhang, L. Yakubov, J. Gervasoni, R. Taub, and S. A. Rotenberg. Dynamics of the internalization of phosphodiester oligodeoxynucleotides in HL60 cells. Biochemistry 32:4855–4861 (1993).
L. Gagné, F. L. Sorgi, D. Tsou, P. Druzgala, and H. Schreier. Gene delivery to hepatocytes using serum-stable, targeted anionic liposomes. J Liposome Res 8:57–58 (1998).
H. Schreier, P. Moran, and I. W. Caras. Targeting of liposomes to cells expressing CD4 using glycosylphosphatidylinositol-anchored gp120. Influence of liposome composition on intracellular trafficking. J Biol Chem 269:9090–9098 (1994).
W. T. Godbey, K. K. Wu, and A. G. Mikos. Tracking the intracellular path of poly(ethylenimine)/DNA complexes for gene delivery. Proc Natl Acad Sci USA 96:5177–5181 (1999).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Welz, C., Neuhuber, W., Schreier, H. et al. Nuclear Transport of Oligonucleotides in HepG2-cells Mediated by Protamine Sulfate and Negatively Charged Liposomes. Pharm Res 17, 1206–1211 (2000). https://doi.org/10.1023/A:1026410612600
Issue Date:
DOI: https://doi.org/10.1023/A:1026410612600